Your browser doesn't support javascript.
loading
Erlotinib plus bevacizumab for EGFR-mutant advanced non-squamous non-small-cell lung cancer patients: ready for first-line?
Adderley, Helen; Ackermann, Christoph Jakob; Califano, Raffaele.
Affiliation
  • Adderley H; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK.
  • Ackermann CJ; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK.
  • Califano R; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK.
Ann Transl Med ; 7(Suppl 8): S346, 2019 Dec.
Article in En | MEDLINE | ID: mdl-32016064
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Ann Transl Med Year: 2019 Document type: Article Country of publication: China
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Ann Transl Med Year: 2019 Document type: Article Country of publication: China